Articles Referencing ALKS

SGEN's Adcetris under FDA Review - Analyst Blog
5/16/2013, 4:29 pm from Zacks.com in Investing, Business, Stocks
Seattle Genetics, Inc. ( SGEN ) recently
announced that the US Food and Drug Administration (FDA) has
accepted its supplemental biologics license application (sBLA)
seeking approval of... Read >>

Cempra/Toyama Ink Deal - Analyst Blog
5/15/2013, 5:29 pm from Zacks.com in Investing, Business, Stocks
Cempra, Inc. ( CEMP ) recently
entered into an exclusive license and development agreement with a
Japanese company, Toyama Chemical Co., Ltd., a subsidiary of
FUJIFILM Holdings ( FUJIY ... Read >>

Much Awaited Test Launch by Genomic - Analyst Blog
5/15/2013, 3:28 pm from Zacks.com in Investing, Business, Stocks
Recently, Genomic Health Inc. ( GHDX ) made available
its lead pipeline candidate Oncotype DX prostate cancer test to
physicians and their patients. This comes as a major boost to... Read >>

Myriad Soars Higher on Celeb Clout - Analyst Blog
5/15/2013, 2:27 pm from Zacks.com in Investing, Business, Stocks
Shares of Myriad Genetics Inc. ( MYGN ) touched a new
52-week high of $34.70 on Tuesday, May 14, 2013 following news out
of Hollywood. Academy Award winning Hollywood star Angelina... Read >>

Isis Gets $3.5M Milestone Payment - Analyst Blog
5/14/2013, 4:05 pm from Zacks.com in Investing, Business, Stocks
Isis Pharmaceuticals Inc. ( ISIS ) recently
announced that it has received a milestone payment of $3.5 million
from its partner, Biogen Idec Inc. ( BIIB ). The milestone
payment was... Read >>

The Week Ahead: Full Slate of Economic Data; Earnings From Cisco, Wal-Mart and Deere
5/10/2013, 9:59 pm from Benzinga in Investing, Economy, International
A host of economic data is set to be released for the week
beginning May 13. Investors will also continue to be focused on
corporate earnings reports from a number of leading companies.
Heading... Read >>

BioMarin Widens Loss, Maintains View - Analyst Blog
4/29/2013, 11:50 am from Zacks.com in Investing, Business, Stocks
BioMarin Pharmaceutical Inc. 's ( BMRN ) first quarter
2013 loss of 31 cents per share was wider than the Zacks Consensus
Estimate of a loss of 28 cents per share and the year-ago loss... Read >>

Illumina Beats on Earnings, Revenue - Analyst Blog
4/23/2013, 3:11 pm from Zacks.com in Investing, Business, Earnings, Stocks
Illumina Inc.'s ( ILMN ) first-quarter
2013 adjusted earnings of 46 cents per share beat the Zacks
Consensus Estimate by 21%. Adjusted earnings grew almost 28% over
the prior-year quarter... Read >>

Zacks Rank #1 Addition for Tuesday - Tale of the Tape
4/23/2013, 9:14 am from Zacks.com in Investing, Investing Ideas, Stocks
Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List
today: Alkermes Plc ( ALKS ) Allied World Assurance Co Holdings, AG ( AWH ) American National BankShares... Read >>

Pipeline Progress at Alkermes - Analyst Blog
4/18/2013, 6:15 pm from Zacks.com in Investing, Business, Stocks
Alkermes ( ALKS ) recently
announced encouraging top-line data from a phase II study (n=142)
on ALKS 5461. The study evaluated the safety and efficacy of ALKS
5461 across two doses for the... Read >>

Market Wrap for Wednesday, April 17: Stocks Plunge Again Along With Euro
4/17/2013, 4:27 pm from Benzinga in Investing, Bonds, Commodities, Futures, International
The U.S. stock market fell sharply on Wednesday as volatility
continues to pick up on Wall Street. Concerns over global growth have caused the recent market
gyrations that have sent the CBOE... Read >>

Mid-Afternoon Market Update: Markets Remain Down, ABIOMED Rises
4/17/2013, 3:35 pm from Benzinga in Investing, Commodities, Economy, International
Toward the end of trading Wednesday, the Dow traded down 0.90
percent to 14,623.12 while the NASDAQ dropped 1.93 percent to
3,201.29. The S&P also fell, declining 1.48 percent... Read >>

Mid-Day Market Update: Cirrus Logic Plunges On Weak Forecast, Atlas Energy Rises
4/17/2013, 12:51 pm from Benzinga in Investing, Commodities, Economy, International
Midway through trading Wednesday, the Dow traded down 1 percent
to 14,609.12 while the NASDAQ dropped 1.94 percent to 3,201.29. The
S&P also fell, declining 1.55 percent to 1,550.18. ... Read >>

Mid-Morning Market Update: Markets Move Lower, Bank of America Posts Downbeat Q1 Profit
4/17/2013, 10:17 am from Benzinga in Investing, Commodities, Economy, International
Following the market opening Wednesday, the Dow traded down 0.62
percent to 14,665.16 while the NASDAQ dropped 0.92 percent to
3,234.63. The S&P also fell, declining 0.80 percent... Read >>

Biotech Alkermes Poised To Swell On Pipeline Wins
4/16/2013, 5:10 pm from Investor's Business Daily in Investing, Investing Ideas
Chief Executive Richard Pops likes to make it very clear about
the company he leads:Alkermes ( ALKS ) is not your
run-of-the mill biotech firm. For one thing, it has a thriving commercial... Read >>